Cargando…

The Extent of Axillary Surgery Is Associated With Breast Cancer-specific Survival in T1–2 Breast Cancer Patients With 1 or 2 Positive Lymph Nodes: A SEER-Population Study

This study aimed to compare the breast cancer-specific survival (BCSS) of a nonclinical trial population of T1–2 breast cancer patients with 1 to 2 positive lymph nodes who received breast-conserving surgery and either sentinel lymph node biopsy (SLNB) or axillary lymph node dissection (ALND). We us...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Shunrong, Liu, Fengtao, Chen, Kai, Rao, Nanyan, Xie, Yufen, Su, Fengxi, Zhu, Liling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2016
Materias:	5750
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998788/ https://www.ncbi.nlm.nih.gov/pubmed/27057872 http://dx.doi.org/10.1097/MD.0000000000003254

Ejemplares similares

Lymphoscintigraphy in patients with breast cancer-related lymphedema after sentinel lymph node dissection and axillary radiation therapy
por: Oh, Se Hyun, et al.
Publicado: (2022)

Male occult breast cancer with axillary lymph node metastasis as the first manifestation: A case report and literature review
por: Xu, Ruixin, et al.
Publicado: (2017)

Volume-based metabolic parameter of breast cancer on preoperative (18)F-FDG PET/CT could predict axillary lymph node metastasis
por: An, Young-Sil, et al.
Publicado: (2017)

Triple mapping for axillary staging after neoadjuvant therapy: Axillary reverse mapping with indocyanine green and dual agent sentinel lymph node biopsy
por: Tasdoven, Ilhan, et al.
Publicado: (2022)

The interplay between hospital and surgeon factors and the use of sentinel lymph node biopsy for breast cancer
por: Yen, Tina W.F., et al.
Publicado: (2016)

Quantification of STAT3 and VEGF expression for molecular diagnosis of lymph node metastasis in breast cancer
por: Chen, Yujuan, et al.
Publicado: (2017)

Is pre-operative axillary ultrasound alone sufficient to determine need for axillary dissection in early breast cancer patients?
por: Jamaris, Suniza, et al.
Publicado: (2021)

Prediction of nodal staging in breast cancer patients with 1-2 sentinel nodes in the Z0011 era
por: Corsi, Fabio, et al.
Publicado: (2020)

Clinical study of combined application of indocyanine green and methylene blue for sentinel lymph node biopsy in breast cancer
por: Zhang, Chenguang, et al.
Publicado: (2021)

Preoperative predictive factors affecting sentinel lymph node positivity in breast cancer and comparison of their effectiveness with existing nomograms
por: Ceylan, Cengiz, et al.
Publicado: (2022)

Better survival in PMRT of female breast cancer patients with >5 negative lymph nodes: A population-based study
por: Wang, Haiyong, et al.
Publicado: (2017)

Management of the axilla with sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer: A single-center study
por: Aksoy, Suleyman Ozkan, et al.
Publicado: (2020)

Prognostic nomogram for female patients suffering from non-metastatic Her2 positive breast cancer: A SEER-based study
por: Wu, Jiangwen, et al.
Publicado: (2022)

Nipple sparing mastectomy in breast cancer patients and long-term survival outcomes: An analysis of the SEER database
por: Li, Mingzhu, et al.
Publicado: (2017)

Prognostic disparities in young patients based on breast cancer subtype: A population-based study from the SEER database
por: Chen, Bing, et al.
Publicado: (2023)

Rethinking on the management strategy of malignant phyllodes tumor of the breast: An analysis based on the SEER database
por: Chen, Chang, et al.
Publicado: (2023)

Establishment of a risk scoring system for predicting locoregional recurrence in T1 to T2 node-negative breast cancer patients treated with mastectomy: Implications for postoperative radiotherapy
por: Li, Jin-luan, et al.
Publicado: (2017)

Prognostic significance of molecular subtype, metastatic site and primary tumor surgery for survival in primary metastatic breast cancer: A SEER-based study
por: Li, Yang, et al.
Publicado: (2021)

Using a novel T-lymph node ratio model to evaluate the prognosis of nonmetastatic breast cancer patients who received preoperative radiotherapy followed by mastectomy: An observational study
por: Wang, Yang, et al.
Publicado: (2017)

Randomized controlled trial of late-course concurrent versus sequential chemoradiotherapy after mastectomy and axillary surgery in locally advanced breast cancer
por: Lu, Ying, et al.
Publicado: (2017)

Adjuvant endocrine therapy alone in patients with node-positive, luminal A type breast cancer
por: Park, Sungmin, et al.
Publicado: (2017)

Aldehyde dehydrogenase 1 expression is correlated with poor prognosis in breast cancer
por: Yao, Juan, et al.
Publicado: (2017)

Expression of mammalian sterile 20-like kinase 1 and 2 and Yes-associated protein 1 proteins in triple-negative breast cancer and the clinicopathological significance
por: Feng, Yang, et al.
Publicado: (2021)

Characterization of Korean Male Breast Cancer Using an Online Nationwide Breast-Cancer Database: Matched-Pair Analysis of Patients With Female Breast Cancer
por: Choi, Min-Young, et al.
Publicado: (2016)

Positive estrogen receptor status is a poor prognostic factor in node-negative breast cancer: An observational study in Asian patients
por: Jung, Eun Jung, et al.
Publicado: (2021)

Breast surgery for young women with early-stage breast cancer: Mastectomy or breast-conserving therapy?
por: Sun, Zhi-Hong, et al.
Publicado: (2021)

Prognostic role of methylated GSTP1, p16, ESR1 and PITX2 in patients with breast cancer: A systematic meta-analysis under the guideline of PRISMA
por: Sheng, Xianneng, et al.
Publicado: (2017)

Impact of WNT1-inducible signaling pathway protein-1 (WISP-1) genetic polymorphisms and clinical aspects of breast cancer
por: Wang, Yan, et al.
Publicado: (2019)

Effect of Implant vs. Tissue Reconstruction on Cancer Specific Survival Varies by Axillary Lymph Node Status in Breast Cancer Patients
por: Ouyang, Qian, et al.
Publicado: (2015)

Refusal of cancer-directed surgery in male breast cancer
por: Wang, Shipei, et al.
Publicado: (2021)

Amplification of HER2 and TOP2A and deletion of TOP2A genes in a series of Taiwanese breast cancer
por: Chen, Jim-Ray, et al.
Publicado: (2017)

Adjuvant therapy for HER2 positive pT1a-b pN0 breast cancer: A single center cohort study
por: Yang, Xuan, et al.
Publicado: (2022)

Identification of potential key genes for HER-2 positive breast cancer based on bioinformatics analysis
por: Lin, Yuxiang, et al.
Publicado: (2020)

Development of nomograms to predict axillary lymph node status in breast cancer patients
por: Chen, Kai, et al.
Publicado: (2017)

The correlation of leukocyte-specific protein 1 (LSP1) rs3817198(T>C) polymorphism with breast cancer: A meta-analysis
por: Chen, Jian, et al.
Publicado: (2022)

Prognostic value of programmed cell death ligand-1 expression in breast cancer: A meta-analysis
por: Zhang, Yingzi, et al.
Publicado: (2020)

Trastuzumab improves locoregional control in HER2-positive breast cancer patients following adjuvant radiotherapy
por: Cao, Lu, et al.
Publicado: (2016)

Prognostic significance of lymphatic vessel invasion diagnosed by D2-40 in Chinese invasive breast cancers
por: He, Ke-Wen, et al.
Publicado: (2017)

Prognostic significance of metabolic enzyme pyruvate kinase M2 in breast cancer: A meta-analysis
por: Yang, Yiming, et al.
Publicado: (2017)

High expression of MORC2 predicts worse neoadjuvant chemotherapy efficacy in triple negative breast cancer
por: Liao, Xiaohong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8i827dnkvpvombekme219vivic